14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of EPIX
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Weaker technical forecast for ESSA Pharma Inc. as stock downgraded to Strong Sell Candidate.
(Updated on Apr 24, 2024)

Sell candidate since Apr 04, 2024 Loss -23.41% PDF

The ESSA Pharma Inc. stock price fell by -2.34% on the last day (Wednesday, 24th Apr 2024) from $6.40 to $6.25. During the last trading day the stock fluctuated 5.04% from a day low at $6.25 to a day high of $6.57. The price has fallen in 6 of the last 10 days and is down by -20.28% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -89 thousand shares and in total, 41 thousand shares were bought and sold for approximately $257.61 thousand.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -19.24% during the next 3 months and, with a 90% probability hold a price between $3.79 and $7.15 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

EPIX Signals & Forecast

There are few to no technical positive signals at the moment. The ESSA Pharma Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $6.66 and $8.21. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Wednesday, February 07, 2024, and so far it has fallen -41.31%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.

Support, Risk & Stop-loss for ESSA Pharma Inc. stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.315 between high and low, or 5.04%. For the last week the stock has had daily average volatility of 10.54%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (EPIX) For The Upcoming Trading Day Of Thursday 25th

For the upcoming trading day on Thursday, 25th we expect ESSA Pharma Inc. to open at $6.36, and during the day (based on 14 day Average True Range), to move between $5.61 and $6.89, which gives a possible trading interval of +/-$0.641 (+/-10.25%) up or down from last closing price. If ESSA Pharma Inc. takes out the full calculated possible swing range there will be an estimated 20.50% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $6.40, some $0.150 (2.40%) from the current price of $6.25, our system finds the risk reward not very attractive.

Is ESSA Pharma Inc. stock A Buy?

ESSA Pharma Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Strong Sell candidate.

Current score: -5.898 Strong Sell Candidate Downgraded

Predicted Opening Price for ESSA Pharma Inc. of Thursday, April 25, 2024

Fair opening price April 25, 2024 Current price
$6.36 ( 1.68%) $6.25

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for EPIX

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 6.67 6.72 %
R2 6.55 4.79 %
R1 6.48 3.61 %
Current price: 6.25
Support S1 6.23 -0.245 %
S2 6.16 -1.43 %
S3 6.04 -3.36 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 7.79 24.64 %
R2 6.80 8.80 %
R1 6.40 2.40 %
Current price 6.25
Support S1 0 .
S2 0 .
S3 0 .

FAQ

What is the symbol for ESSA Pharma Inc. Stock and on which exchange is it traded?
The symbol for ESSA Pharma Inc. is EPIX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell ESSA Pharma Inc. Stock?
ESSA Pharma Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Strong Sell candidate.

How to buy ESSA Pharma Inc. Stock?
ESSA Pharma Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy ESSA Pharma Inc. Stock.

What's the current price of ESSA Pharma Inc. Stock?
As of the end of day on the Apr 24, 2024, the price of an ESSA Pharma Inc. (EPIX) share was $6.25.

What is the 52-week high and low for ESSA Pharma Inc. Stock?
The 52-week high for ESSA Pharma Inc. Stock is $11.67 and the 52-week low is $2.56.

What is the market capitalization of ESSA Pharma Inc. Stock?
As of the Apr 24, 2024, the market capitalization of ESSA Pharma Inc. is 276.488M.

When is the next earnings date for ESSA Pharma Inc.?
The upcoming earnings date for ESSA Pharma Inc. is May 14, 2024.
Click to get the best stock tips daily for free!

About ESSA Pharma Inc.

ESSA Pharma. ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company has collaboration agreements with Caris Life Sciences, Inc.; Bayer Consumer Care AG; Janssen Research & Development, LLC; and A... EPIX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT